Pharmicell Co Ltd
KRX:005690
Intrinsic Value
Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. [ Read More ]
The intrinsic value of one Pharmicell Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 5 560 KRW, Pharmicell Co Ltd is hidden .
Valuation Backtest
Pharmicell Co Ltd
Run backtest to discover the historical profit from buying and selling Pharmicell Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Pharmicell Co Ltd
Current Assets | 43.2B |
Cash & Short-Term Investments | 14B |
Receivables | 7.8B |
Other Current Assets | 21.3B |
Non-Current Assets | 49.4B |
Long-Term Investments | 45.7m |
PP&E | 40.7B |
Intangibles | 5.6B |
Other Non-Current Assets | 3B |
Current Liabilities | 7.8B |
Accounts Payable | 1.8B |
Accrued Liabilities | 661.8m |
Other Current Liabilities | 5.3B |
Non-Current Liabilities | 4.4B |
Long-Term Debt | 390.2m |
Other Non-Current Liabilities | 4B |
Earnings Waterfall
Pharmicell Co Ltd
Revenue
|
56.2B
KRW
|
Cost of Revenue
|
-40.7B
KRW
|
Gross Profit
|
15.5B
KRW
|
Operating Expenses
|
-14.2B
KRW
|
Operating Income
|
1.3B
KRW
|
Other Expenses
|
2.3B
KRW
|
Net Income
|
3.6B
KRW
|
Free Cash Flow Analysis
Pharmicell Co Ltd
Profitability Score
Profitability Due Diligence
Pharmicell Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Pharmicell Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Pharmicell Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Pharmicell Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Pharmicell Co Ltd
According to Wall Street analysts, the average 1-year price target for Pharmicell Co Ltd is 17 500 KRW .
Shareholder Return
Price
Pharmicell Co Ltd
Average Annual Return | 11.96% |
Standard Deviation of Annual Returns | 56.94% |
Max Drawdown | -79% |
Market Capitalization | 333.6B KRW |
Shares Outstanding | 60 004 050 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. The company is headquartered in Seoul, Seoul and currently employs 127 full-time employees. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. The company also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides women’s and men’s apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.
Contact
IPO
Employees
Officers
The intrinsic value of one Pharmicell Co Ltd stock under the Base Case scenario is hidden KRW.
Compared to the current market price of 5 560 KRW, Pharmicell Co Ltd is hidden .